Five hundred and twenty two clinical urine specimens submitted for routine microbiological examination were tested in parallel by conventional microscopy and culture and for lipopolysaccharide antibodies by an enzyme linked immunoabsorbent assay (ELISA) to assess the ELISA as a screen for urinary tract infection. When the ELISA alone was compared with routine methods the specificity sensitivity, and predictive value of positive and negative tests was 73-2%, 75 7%, 51-1% and 38-5%. For ELISA with microscopy the same variables were 71-1%, 82-2%, and 92-4% and 94 7%, respectively. The ELISA absorbency increased with increasing bacterial numbers, but results varied widely. Only 65-4% of urines which contained > 105 bacterial/ml were positive by ELISA; 36-8% of urines with < 103 bacterialml were positive by ELISA; 100% of > 105 bacteria/ml cultures of Pseudomonas sp (n = 4), Staphylococcus aureus (n = 3), and Streptococcus faecalis (n = 2) were positive by ELISA but only 71-4% of Proteus sp (n = 7), 61-4% coliforms (n = 70), and 25% of coagulase negative staphylococci (n = 4).
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It is concluded that further development is required before the ELISA can be used for routine screening for urinary tract infection. Secretory IgA may, however, be detected in patients with cystitis or asymptomatic bacteriuria.'5 Hence it has been suggested that the detection of antibodies by the use of a polyspecific lipopolysaccharide antigen in an ELISA may provide a useful screening test for urine before culture or that it could replace microscopy. 6 We report on the evaluation of a prototype ELISA (Melisa, Utilisa) developed by Walker Diagnostics, Cambridge, England, for the detection of urinary lipopolysaccharide antibody and the evaluation of its role as a screening test for urinary tract infection.
Methods
Conventional urine microscopy and culture on CLED agar were performed on all specimens. An inverted microscope was used on 60 jl of urine in 96-well flat bottomed microtitre trays. Red blood and white cellcounts were expressed per high power field. Culture comprised a 2 ,ul standard loop on to a half plate for each specimen. Urine specimens with no growth after 18 hours of incubation were assumed to have < 103 bacteria/ml. In parallel, urine specimens were also tested using the manufacturer's recommendations in a solid phase enzyme linked immunoabsorbent assay (ELISA) for detection of lipopolysaccharide antibodies (Walker Diagnostics Cambridge, Cambridgeshire, England).
Briefly, 200 pl of positive and control reagent with a defined absorbency cut-off as well as test urines were pipetted into 96-well microtitre trays and pins coated with purified lipopolysaccharide were inserted and incubated for 10 minutes at room temperature. The pins were washed and transferred to 100 ,ul of enzyme conjugate in a second plate and incubated for a further 10 minutes. The pins were washed again and placed in 200 jul of enzyme substrate (0-phenylenediamine-hydrochloride).
The reaction was stopped by the addition of 50 ,ul 4M sulphuric acid after 10 minutes.
The optical density was read at 492 nm on a microplate reader. For each assay the samples were compared with the cut off value (COV). Samples with absorbency lower than the COV were negative, and those greater were positive, provided the positive control was more than five times the COV optical density. To enable optical densities to be compared between different ELISA plates a "corrected absorbency" was derived by multiplying the test One hundred and six (20-3%) were positive by conventional methods-60 (24-3%) from general practice, and 46 (16-7%) from hospital patients. The ELISA by itself and in combination with pyuria or haematuria, or both (> 10 red blood cells/high power field) was compared with conventional microscopy and culture. For comparison, routine microscopy was also compared with microscopy and culture. Table 1 shows the sensitivities, specificities, and predictive values of these tests for urine samples from hospital and general practice patients.
ELISA and microscopy combined had a negative predictive value of 94-7% for all urine specimens while the corresponding figures for microscopy or ELISA alone were 92-2 and 92-4%, respectively. The specificity of the ELISA was less than microscopy alone, and the positive predictive value of all the tests was less in hospital than general practice patients.
There Table 4 shows the percentage of urine samples positive by conventional methods at different corrected absorbencies. As the absorbency increases the percentage ofpositive urine samples increased from 5-10% to about 40%, but even at high optical densities only 39% of urines were judged positive by conventional culture. If the average COV (0179) is compared with the range of absorbencies then it lies near the majority of the results; hence small Changing the cut offvalue in the ELI SA will change the specificity and sensitivity ofthe test, but as only 40% of urine samples with high absorbencies are positive by conventional tests, and 5-10% of those with low absorbencies, a greater difference in these percentages would be needed to make this worthwhile.
At present the prototype ELISA under test as a screening method for urinary tract infection lacks the technical characteristics which would make it suitable in this role, mainly because of the high number offalse positive and negative results when compared with conventional microscopy and culture. This may be because of problems with conventional methods such as the presence of antibiotic or a significant number of bacteria at less than 10' cfu/ml in the urine, both of which would produce false positive results by ELISA. False negative results may occur because of the inability of the test to detect the full range of antibody classes or specificities produced in response to a urinary tract infection, or by failures of a patient to mount an antibody response-for example, immunocompromised hospital patients. If some ofthese problems can be overcome studies of workloads and costs could be performed.
